Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl preinduction to reduce propofol dose and hypotension for LMA insertion
TCTR20250513006Phase 4Recruiting
- Sponsor
- Chiang Mai University
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fentanyl in hypotension (2 arms), sponsored by Chiang Mai University. Primary endpoints: Propofol dose required for LMA insertion and Incidence of hypotension during and after induction. Started Apr 2025; status: recruiting.
02
Drugs
fentanyl
03
Conditions
hypotension
Beyond the preview
Go deeper on TCTR20250513006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250513006.